Acne study boosts Biome shares by circa ten per cent
MELBOURNE: ASX-listed complementary medicines small cap Biome Australia has jumped 10 per cent ... read more
Telix Pharmaceuticals pushes back EU regulator deadlines
MELBOURNE: Cancer fighter Telix Pharmaceuticals has been granted extra time to answer questions ... read more










